AWAnne J. Wanders

Anne J. Wanders

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne J. Wanders has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A series of N-of-1 dietary intervention studies with whole-grain foods and nuts reveals individual predictors of blood pressure and heart rate

    by Tilly I. T. Potter, Fieke Pepping, Anne J. Wanders, Elizabeth H. Zandstra, Peter L. Zock, Rikard Landberg, Rute Vieira, Baukje de Roos

    Background/objectives: To determine predictors of systolic and diastolic blood pressure (SBP/DBP), of heart rate, and of whole-grains and nuts consumption, on an individual level, using a series of N-of-1 studies. Methods: Participants were enrolled in individual 24-wk N-of-1 studies, consisting of 8-wk observation, intervention, and follow-up periods. Participants completed personalized morning and evening questionnaires and took their own blood pressure daily. During the intervention period, participants received 3–4 portions of whole-grains and a portion of nuts daily. Fasted blood samples were collected every 4 weeks for analysis of lipids and plasma alkylresorcinol concentrations. Dynamic regression modeling was used to determine factors associated with changes in blood pressure, heart rate, and compliance with the intervention. Results: 12 participants completed their study, with 11 collecting enough data to permit analysis. Dynamic regression modeling identified variables significantly affecting individual blood pressure, heart rate, and consumption of whole-grains and nuts, including sleep quality, weekday, motivation to eat well, alcohol consumption, day of menstrual cycle, outside temperature, and physical activity. Consumption of whole-grains and nuts was associated with a significant ( p < 0.01) decrease in SBP for one participant, a significant ( p < 0.05) decrease in DBP for two participants, and a significant ( p < 0.01) lowering in heart rate for five participants. Conclusions: The N-of-1 studies uniquely identified individual-level factors that were associated with changes in blood pressure and heart rate, and with compliance to consumption of whole-grains and nuts. N-of-1 studies are imperative to better understand heterogeneity of response and to develop more targeted, personalized and acceptable dietary advice. Trial Registration: https://clinicaltrials.gov/study/NCT04326686 . First registered 20 March 2020.

  • Open Access

    Replacing Animal Meat with Plant-Based Meat Alternatives: The Impact of Protein Quality on Protein Adequacy in the Dutch Diet

    by Anne J Wanders, Samantha N Heerschop, Sander Biesbroek, Mariska Dötsch-Klerk


  • Open Access

    Satiating Capacity of Plant-Based Meat in Realistic Meal Contexts at Home

    by Elizabeth H. Zandstra, Ilse A. Polet, Gertrude G. Zeinstra, Anne J. Wanders, Garmt B. Dijksterhuis

    Plant-based meat substitutes replacing animal meat can potentially support the transition towards more sustainable diets. To enable the required transition, consumer acceptance of plant-based meat is essential. An important aspect of this is the feeling of satiety or being full after eating. This study determined the satiating capacity of both plant-based meat and animal meat in 60 adults under real-life in-home conditions. Participants consumed four fixed ready-to eat meals for lunch at home once per week. Two types of Indian curry with ‘chicken’ were investigated as well as two types of pasta Bolognese with ‘minced meat’. The two ‘chicken’ dishes and the two ‘minced meat’ dishes had the same recipe except for a gram-for-gram swap (125 g each) of either animal meat (chicken breast and minced meat) or plant-based (soy) meat. Results showed no difference in the satiating power of an animal meat dish and a plant-based meat dish when these were eaten as part of a full lunch meal at home. In addition, the meals did not result in energy nor macronutrient compensation during the rest of the day after consuming the meals. This occurred despite the caloric differences of the meals as a result of the real-life conditions (i.e., a lower energy content of the pasta with plant-based meat compared to the other meals). We conclude that meals with plant-based meat can be as satiating as meals with animal meat.


  • Open Access

    An Examination of the Associations between Nutritional Composition, Social Jet Lag and Temporal Sleep Variability in Young Adults

    by Piril Hepsomali, Elizabeth H. Zandstra, Anne J. Wanders, Barry V. O’neill, Pamela Alfonso-Miller, Jason G. Ellis

    While dietary intake has previously been related to various indices of poor sleep (e.g., short sleep duration, poor sleep quality), to date, few studies have examined chrononutrition from the perspectives of the relationship between dietary intake and social jet lag and temporal sleep variability. Moreover, recently it has been suggested that previous methods of measuring social jet lag have the potential to lead to large overestimations. Together, this precludes a clear understanding of the role of nutritional composition in the pathophysiology of poor sleep, via social jet lag and temporal sleep variability, or vice versa. The aim of the present study was to determine the relationships between nutrient intake and social jet lag (using a revised index, taking account of intention to sleep and sleep onset and offset difficulties), and temporal sleep variability. Using a cross-sectional survey, 657 healthy participants (mean age 26.7 ± 6.1 years), without sleep disorders, were recruited via an online platform and completed measures of weekly dietary intake, social jet lag, temporal sleep variability, stress/sleep reactivity and mood. Results showed limited associations between nutritional composition and social jet lag. However, levels of temporal sleep variability were predicted by consumption of polyunsaturated fats, sodium, chloride and total energy intake. The results suggest further examinations of specific nutrients are warranted in a first step to tailoring interventions to manage diet and temporal variabilities in sleep patterns.


  • Open Access

    Quantifying the contribution of triglycerides to metabolic resilience through the mixed meal model

    by Shauna D. O’dOnovan, Balázs Erdős, Doris M. Jacobs, Anne J. Wanders, E. Louise Thomas, Jimmy D. Bell, Milena Rundle, Gary Frost, Ilja C.W. Arts, Lydia A. Afman, et al.


  • Open Access

    Protein quality of soy and the effect of processing: A quantitative review

    by Lisa A. van Den Berg, Jurriaan J. Mes, Marco Mensink, Anne J. Wanders

    There is a growing demand for plant-based protein-rich products for human consumption. During the production of plant-based protein-rich products, ingredients such as soy generally undergo several processing methods. However, little is known on the effect of processing methods on protein nutritional quality. To gain a better understanding of the effect of processing on the protein quality of soy, we performed a quantitative review of in-vivo and in-vitro studies that assessed the indispensable amino acid (IAA) composition and digestibility of varying soy products, to obtain digestibility indispensable amino acids scores (DIAAS) and protein digestibility corrected amino acid scores (PDCAAS). For all soy products combined, mean DIAAS was 84.5 ± 11.4 and mean PDCAAS was 85.6 ± 18.2. Data analyses showed different protein quality scores between soy product groups. DIAAS increased from tofu, soy flakes, soy hulls, soy flour, soy protein isolate, soybean, soybean meal, soy protein concentrate to soymilk with the highest DIAAS. In addition, we observed broad variations in protein quality scores within soy product groups, indicating that differences and variations in protein quality scores may also be attributed to various forms of post-processing (such as additional heat-treatment or moisture conditions), as well as study conditions. After excluding post-processed data points, for all soy products combined, mean DIAAS was 86.0 ± 10.8 and mean PDCAAS was 92.4 ± 11.9. This study confirms that the majority of soy products have high protein quality scores and we demonstrated that processing and post-processing conditions can increase or decrease protein quality. Additional experimental studies are needed to quantify to which extent processing and post-processing impact protein quality of plant-based protein-rich products relevant for human consumption.


  • Open Access

    Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials

    by Anne J Wanders, Wendy A M Blom, Peter L Zock, Johanna M Geleijnse, Ingeborg A Brouwer, Marjan Alssema

    The objective of this meta-analysis was to investigate the effects of plant-derived polyunsaturated fatty acids (PUFAs) on glucose metabolism and insulin resistance. Scopus and PubMed databases were searched until January 2018. Eligible studies were randomized controlled feeding trials that investigated the effects of a diet high in plant-derived PUFA as compared with saturated fatty acids (SFA) or carbohydrates and measured markers of glucose metabolism and insulin resistance as outcomes. Data from 13 relevant studies (19 comparisons of plant-derived PUFA with control) were retrieved. Plant-derived PUFA did not significantly affect fasting glucose (−0.01 mmol/L (95 % CI − 0.06 to 0.03 mmol/L)), but lowered fasting insulin by 2.6 pmol/L (−4.9 to −0.2 pmol/L) and homeostatic model assessment-insulin resistance (HOMA-IR) by 0.12 units (-0.23 to − 0.01 units). In dose–response analyses, a 5% increase in energy (En%) from PUFA significantly reduced insulin by 5.8 pmol/L (95% CI −10.2 to −1.3 pmol/L), but not glucose (change −0.07, 95% CI −0.17 to 0.04 mmol/L) and HOMA-IR (change − 0.24, 95% CI −0.56 to 0.07 units). In subgroup analyses, studies with higher PUFA dose (upper tertiles) reduced insulin (-6.7, –10.5 to −2.9 pmol/L) and HOMA-IR (-0.28, –0.45 to −0.12 units), but not glucose (−0.09, 95% CI −0.18 to 0.01 mmol/L), as compared with an isocaloric control. Subgroup analyses showed no differences in effects between SFA and carbohydrates as replacement nutrients (p interaction ≥0.05). Evidence from randomized controlled trials indicated that plant-derived PUFA as an isocaloric replacement for SFA or carbohydrates probably reduces fasting insulin and HOMA-IR in populations without diabetes.


  • Open Access

    Trans Fat Intake and Its Dietary Sources in General Populations Worldwide: A Systematic Review

    by Anne J. Wanders, Peter L. Zock, Ingeborg A. Brouwer

    After the discovery that trans fat increases the risk of coronary heart disease, trans fat content of foods have considerably changed. The aim of this study was to systematically review available data on intakes of trans fat and its dietary sources in general populations worldwide. Data from national dietary surveys and population studies published from 1995 onward were searched via Scopus and websites of national public health institutes. Relevant data from 29 countries were identified. The most up to date estimates of total trans fat intake ranged from 0.3 to 4.2 percent of total energy intake (En%) across countries. Seven countries had trans fat intakes higher than the World Health Organization recommendation of 1 En%. In 16 out of 21 countries with data on dietary sources, intakes of trans fat from animal sources were higher than that from industrial sources. Time trend data from 20 countries showed substantial declines in industrial trans fat intake since 1995. In conclusion, nowadays, in the majority of countries for which data are available, average trans fat intake is lower than the recommended maximum intake of 1 En%, with intakes from animal sources being higher than from industrial sources. In the past 20 years, substantial reductions in industrial trans fat have been achieved in many countries.


  • Dietary fatty acid intake after myocardial infarction: a theoretical substitution analysis of the Alpha Omega Cohort

    by Famke Jm Mölenberg, Janette de Goede, Anne J Wanders, Peter L Zock, Daan Kromhout, Johanna M Geleijnse

    Background: Replacement of saturated fatty acids (SFAs) with unsaturated fatty acids (UFAs), especially polyunsaturated fatty acids (PUFAs), has been associated with a lower risk of ischemic heart disease (IHD). Whether this replacement is beneficial for drug-treated patients with cardiac disease is not yet clear. Objective: In a prospective study of Dutch patients with cardiac disease (Alpha Omega Cohort), we examined the risk of cardiovascular disease (CVD) and IHD mortality when the sum of SFAs and trans fatty acids (TFAs) was theoretically replaced by total UFAs, PUFAs, or cis monounsaturated fatty acids (MUFAs). Design: We included 4146 state-of-the-art drug-treated patients aged 60–80 y with a history of myocardial infarction (79% male patients) and reliable dietary data at baseline (2002–2006). Cause-specific mortality was monitored until 1 January 2013. HRs for CVD mortality and IHD mortality for theoretical, isocaloric replacement of dietary fatty acids (FAs) in quintiles (1–5) and continuously (per 5% of energy) were obtained from Cox regression models, adjusting for demographic factors, medication use, and lifestyle and dietary factors. Results: Patients consumed, on average, 17.5% of energy of total UFAs, 13.0% of energy of SFAs, and cis MUFA quintiles were nonsignificant. HRs were similar for IHD mortality. In continuous analyses, replacement of SFAs plus TFAs with total UFAs, PUFAs, or cis MUFAs (per 5% of energy) was associated with significantly lower risks of CVD mortality (HRs between 0.68 and 0.75) and IHD mortality (HRs between 0.55 and 0.70). Conclusion: Shifting the FA composition of the diet toward a higher proportion of UFAs may lower CVD mortality risk in drug-treated patients with cardiac disease. This study was registered at clinicaltrials.gov as NCT03192410.